Breast cancer risk assessment and prevention: a framework for shared decision-making consultations (Q36410469)

14 August 2017

1 reference

title

Breast cancer risk assessment and prevention: a framework for shared decision-making consultations (English)

1 reference

14 August 2017

1 reference

3

Laura J Esserman

1 reference

14 August 2017

Elissa M Ozanne

1

1 reference

14 August 2017

Jennifer R Klemp

series ordinal

2

1 reference

14 August 2017

publication date

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

12

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

103-113

1 reference

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Informed decision making in outpatient practice: time to get back to basics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Application of breast cancer risk prediction models in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Future possibilities in the prevention of breast cancer: luteinizing hormone-releasing hormone agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

New approaches to the endocrine prevention and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Diet, nutrition and the prevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Consumption of vegetables and fruits and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Does diet affect breast cancer risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Chemoprevention of breast cancer: recommendations and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Breast cancer risk reduction: strategies for women at increased risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Current comprehensive assessment and management of women at increased risk for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Benign breast disease and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Obesity as a risk factor in venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

The Potential Benefits of Decision Aids in Clinical Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2006.00217.X

10.1111/J.1075-122X.2006.00217.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference